通过合作减少心力衰竭再入院:急性护理和急性后成功故事
概括
在急性后护理设施中实施心力衰竭疾病管理计划 (HFDMP) 显著减少了30天的再入院,从20%降至2.78%. 这项质量改进项目证明了管理心力衰竭患者和改善资源使用的成功策略.
科学领域:
- 心脏病学 心脏病学
- 医疗保健管理的管理
- 提高质量 提高质量
背景情况:
- 心力衰竭 (HF) 是美国住院的主要原因.
- 预计HF发病率将上升,增加急性后护理设施的利用率.
- 现有研究表明,心力衰竭疾病管理计划 (HFDMP) 可以减少医院再入院.
研究的目的:
- 在后急性护理环境中实施和评估HFDMP.
- 评估HFDMP对30天心力衰竭患者再入院率的影响.
- 改善心力衰竭管理的急性后护理资源利用率.
主要方法:
- 一个跨学科的团队开发和实施了一个HFDMP.
- 关键组成部分包括员工培训,饮食手册重新设计,增强排放工作流程,专用高频单元和供应优化.
- 确定了用于监测计划成功的指标.
主要成果:
- 心力衰竭患者的30天再入院率从计划前的20%下降到实施后的2.78%.
- 实施后,仅有一名居民因与高频无关的条件而被重新录取.
- 该计划表明,与高频相关的再录取人数显著减少.
结论:
- 在急性后护理设施中实施HFDMP为减少30天再入院提供了巨大的机会.
- 这种方法可以改善患者的治疗结果和更有效的资源配置.
- 该研究强调了HFDMPs的可扩展性,以便在急性后护理环境中在全国采用.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
526
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.1K
相关概念视频
Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
Acute Coronary Syndrome IV: Interprofessional Care
219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Heart Failure VII: Nursing Interventions
416
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
416
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
